Laura Rosen

2.2k total citations · 1 hit paper
31 papers, 1.8k citations indexed

About

Laura Rosen is a scholar working on Molecular Biology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Laura Rosen has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cognitive Neuroscience and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Laura Rosen's work include Sleep and Wakefulness Research (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Sleep and related disorders (6 papers). Laura Rosen is often cited by papers focused on Sleep and Wakefulness Research (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Sleep and related disorders (6 papers). Laura Rosen collaborates with scholars based in United States, United Kingdom and Japan. Laura Rosen's co-authors include Michael E. Greenberg, Charles L. Farnsworth, Anirvan Ghosh, Larry A. Feig, M. E. Greenberg, David D. Ginty, Joseph A. Majzoub, Gail K. Adler, Ka Lai Yee and Nicole Calder and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Laura Rosen

29 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras

1994 625 citations Laura Rosen Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Rosen United States	16	1.0k	623	293	273	227	31	1.8k
Sandi Jo Estill United States	17	680 0.7×	399 0.6×	332 1.1×	461 1.7×	582 2.6×	20	1.9k
Graham H. Diering United States	15	842 0.8×	960 1.5×	487 1.7×	208 0.8×	148 0.7×	29	1.9k
Rugao Liu United States	24	744 0.7×	433 0.7×	231 0.8×	576 2.1×	395 1.7×	28	2.0k
Kari R. Hoyt United States	25	1.1k 1.1×	1.0k 1.6×	142 0.5×	390 1.4×	317 1.4×	42	2.1k
Maisie Lo United States	13	841 0.8×	1.0k 1.7×	757 2.6×	94 0.3×	155 0.7×	18	2.4k
Inês M. Araújo Portugal	22	675 0.7×	728 1.2×	100 0.3×	244 0.9×	91 0.4×	52	1.6k
Marco Milanese Italy	30	900 0.9×	888 1.4×	233 0.8×	295 1.1×	104 0.5×	88	2.5k
Jean‐Michel Arrang France	31	2.6k 2.5×	521 0.8×	228 0.8×	529 1.9×	573 2.5×	61	4.1k
Weiqi Zhang Germany	19	540 0.5×	693 1.1×	247 0.8×	129 0.5×	40 0.2×	37	1.6k
Virginia L. Smith‐Swintosky United States	23	734 0.7×	694 1.1×	130 0.4×	723 2.6×	62 0.3×	35	2.0k

Countries citing papers authored by Laura Rosen

Since Specialization

Citations

This map shows the geographic impact of Laura Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Rosen more than expected).

Fields of papers citing papers by Laura Rosen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Rosen. The network helps show where Laura Rosen may publish in the future.

Co-authorship network of co-authors of Laura Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Rosen. A scholar is included among the top collaborators of Laura Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Rosen. Laura Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hawkins, Peter C.T., Adam J. Schwarz, James Stone, et al.. (2025). The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial. Psychopharmacology.

Osman, A, Sutapa Mukherjee, Kelly A. Loffler, et al.. (2024). A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity. Sleep Medicine. 115. S326–S326.

O’Donnell, Patricio, Mahnaz Asgharnejad, Xiaoming Du, et al.. (2023). The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial. Neuropsychopharmacology. 48(7). 1052–1059. 34 indexed citations

Evans, Rebecca, Haruhide Kimura, Masato Nakashima, et al.. (2023). Orexin 2 receptor‐selective agonist danavorexton (TAK‐925) promotes wakefulness in non‐human primates and healthy individuals. Journal of Sleep Research. 32(5). e13878–e13878. 16 indexed citations

O’Donnell, Patricio, Erica S. Klaassen, Derek L. Buhl, et al.. (2022). Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers. Translational Psychiatry. 12(1). 408–408. 17 indexed citations

O’Donnell, Patricio, Quanhong Lei, Lin Xu, et al.. (2021). Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation. Translational Psychiatry. 11(1). 325–325. 11 indexed citations

Rosen, Laura, et al.. (2017). 1164 THE USE OF CHEMICAL NEURO STIMULATION TO MINIMIZE SLEEP DISTURBANCE ASSOCIATED WITH MUSCLE CRAMPING AND SPASTICITY. SLEEP. 40(suppl_1). A434–A435. 1 indexed citations

Cebers, Gvido, Robert Alexander, Samantha Budd Haeberlein, et al.. (2016). AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease. Journal of Alzheimer s Disease. 55(3). 1039–1053. 68 indexed citations

Gotter, Anthony L., Mark S. Forman, C. Meacham Harrell, et al.. (2016). Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man. Scientific Reports. 6(1). 27147–27147. 67 indexed citations

10.

Sun, Hong, William P. Kennedy, Darren Wilbraham, et al.. (2013). Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men. SLEEP. 36(2). 259–67. 132 indexed citations

11.

Sun, Hong, Catherine MacLeod, Lingling Han, et al.. (2013). Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients. The Journal of Clinical Pharmacology. 53(12). 1294–1302. 9 indexed citations

12.

Kennedy, David O., Nicole Lewis, Tine Laethem, et al.. (2012). The single dose pharmacokinetic (PK) and pharmacodynamic (PD) profiles of suvorexant (MK-4305); a dual orexin receptor antagonist, in healthy male subjects. Ghent University Academic Bibliography (Ghent University). 8 indexed citations

13.

Iannone, Raffaele, B.R. Bloem, John Palcza, et al.. (2011). The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol. Journal of Psychopharmacology. 26(2). 292–302. 16 indexed citations

14.

Dychter, Samuel S., Ramesh K. Ramanathan, Jon Infante, et al.. (2011). PP 60 Targeting hyaluronan in tumor stroma. Interim translational and biomarker evaluations of pegylated hyaluronidase (PEGPH20) in animal models and patients with advanced solid tumors. European Journal of Cancer. 47. S30–S31. 2 indexed citations

15.

Pequignot, Edward, Deborah Panebianco, Paul Lupinacci, et al.. (2006). Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers. The Journal of Clinical Pharmacology. 46(7). 792–801. 12 indexed citations

16.

Rosen, Laura & Michael E. Greenberg. (1996). Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels.. Proceedings of the National Academy of Sciences. 93(3). 1113–1118. 161 indexed citations

17.

Farnsworth, Charles L., et al.. (1995). Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature. 376(6540). 524–527. 371 indexed citations

18.

Rosen, Laura, David D. Ginty, & M. E. Greenberg. (1995). 7 Calcium regulation of gene expression. PubMed. 30. 225–253. 96 indexed citations

19.

Rosen, Laura. (1994). Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron. 12(6). 1207–1221. 625 indexed citations breakdown →

20.

Adler, Gail K., Laura Rosen, Mark J. Fiandaca, & Joseph A. Majzoub. (1992). Protein kinase-C activation increases the quantity and poly(A) tail length of corticotropin-releasing hormone messenger RNA in NPLC cells.. Molecular Endocrinology. 6(3). 476–484. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact